Genetic Variants in the MRPS30 Region and Postmenopausal Breast Cancer Risk

Genome Medicine - United Kingdom
doi 10.1186/gm318
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Breast Cancer Risk Assessment Using Genetic Variants and Risk Factors in a Singapore Chinese Population

Breast Cancer Research
Cancer ResearchOncology
2014English

Genetic Variants in the Acylphosphatase 2 Gene and the Risk of Breast Cancer in a Han Chinese Population

Oncotarget
Oncology
2016English

Association of FGFR2 and PI3KCA Genetic Variants With the Risk of Breast Cancer in a Chinese Population

Cancer Management and Research
Oncology
2018English

Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2017English

Frequency of 14 Genetic Variants Associated With Breast Cancer Risk and Treatment in a Colombian Population

Revista Colombiana de Ciencias Químico-Farmacéuticas
2018English

Genetic Variants in COX-2, Non-Steroidal Anti-Inflammatory Drugs, and Breast Cancer Risk: The Western New York Exposures and Breast Cancer (WEB) Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Correction: A Meta-Analysis of the Association Between ESR1 Genetic Variants and the Risk of Breast Cancer

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy